The antiferroptotic role of TRIM7: Molecular mechanism and synergistic effect with temozolomide

Area of Science:

• Cellular biology
• Molecular mechanisms of cell death
• Cancer research

Background:

• Nuclear receptor coactivator 4 (NCOA4) is a key regulator of ferritinophagy, a process involving lysosomal degradation of ferritin.
• Ferritinophagy releases iron, influencing cellular iron homeostasis and cell death pathways.
• Glioblastoma, a brain tumor, exhibits complex regulation of cell death mechanisms.

Purpose of the Study:

• To investigate the role of TRIM7 in regulating ferroptosis in glioblastoma cells.
• To elucidate the mechanism by which TRIM7 affects NCOA4 function and ferritinophagy.
• To understand the implications of TRIM7-mediated NCOA4 regulation in glioblastoma cell survival.

Main Methods:

• Cell culture models of glioblastoma
• Overexpression of TRIM7
• Immunoblotting to detect protein levels and ubiquitination
• Immunofluorescence to assess NCOA4 localization
• Assessment of ferritinophagy and ferroptosis markers

Main Results:

• TRIM7 overexpression was found to inhibit ferroptosis in glioblastoma cells.
• TRIM7 directly interacts with and ubiquitinates NCOA4 protein.
• Ubiquitination of NCOA4 by TRIM7 disrupts its function as a cargo receptor for ferritin.
• This disruption leads to impaired ferritinophagy and reduced iron release, promoting glioblastoma cell survival.

Conclusions:

• TRIM7 acts as an inhibitor of ferroptosis in glioblastoma by targeting NCOA4 for ubiquitination.
• The TRIM7-NCOA4 axis represents a novel regulatory mechanism in glioblastoma cell death.
• Targeting the TRIM7-NCOA4 interaction could be a potential therapeutic strategy for glioblastoma.